On September 11, 2026, DataMeds AI, Inc. completed the acquisition of Helomics Corporation from Axe Compute Inc. for a total consideration valued at $1.5 million, consisting of 636,328 shares of common stock (approximately 19.99% of pre-transaction outstanding shares) and a convertible promissory note with a principal amount of $1,363,672.00. The note accrues interest at 7% per annum, matures on September 11, 2029, and converts to common stock at $1.00 per share upon stockholder approval. Helomics operates as a CLIA/CAP-certified AI cancer diagnostics laboratory and precision oncology CRO business. DataMeds AI, Inc. is a Health IT company that vertically integrates technology, pharmacy, pharmaceutical-adjacent services, and telemedicine to deliver healthcare experiences.

Datavault AI Inc. is distributing Dream Bowl 2026 Meme Coin tokens to DataMEDS AI, Inc. common stockholders as a licensing partner appreciation token. The distribution rate is fifty (50) Meme Coins per share of DataMEDS Common Stock held on the record date of August 7, 2026. Payment begins September 9, 2026, contingent upon shareholders setting up a digital wallet and submitting an opt-in agreement. Each Meme Coin had a fair market value of $0.01 as of the valuation date. This distribution is voluntary and subject to revocation by Datavault's board prior to payment. DataMEDS AI, Inc. operates in the artificial intelligence industry.